Moneycontrol
Oct 19, 2016 03:38 PM IST IST | Source: Moneycontrol.com

Lupin Q2 PAT seen down 28.6% to Rs 630 cr: Centrum

Net Sales are expected to decrease by 3.6 percent Q-o-Q (up 28.9 percent Y-o-Y) to Rs 4280 crore, according to Centrum.


Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Lupin to report net profit at Rs 630 crore, down 28.6 percent quarter-on-quarter.


Net Sales are expected to decrease by 3.6 percent Q-o-Q (up 28.9 percent Y-o-Y) to Rs 4280 crore, according to Centrum.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 19 percent Q-o-Q (up 57.6 percent Y-o-Y) to Rs 1059 crore.

Centrum's report on Lupin

The net profit would grow by 54% YoY to Rs6.30bn from Rs 4.09bn due to strong revenue growth and margin improvement.

We expect Lupin to benefit from the acquisition of Gavis, US, FY17 onwards.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Sections
Follow us on
Available On